FBR Limited (ASX:FBR), a Western Australia-based robotics technology firm, has secured a convertible note financing agreement with SBC Global Investment Fund. The initial funding commitment totals AUD$900,000, disbursed in two equal tranches of AUD$450,000 each, with an option for up to AUD$2.97 million in additional drawdowns. This facility equips FBR with essential capital to cover operational costs and working capital, while minimizing dilution effects for current shareholders.
Key Highlights
- FBR Limited (ASX:FBR) is headquartered at 88 Sultana Road West, High Wycombe, Western Australia, specializing in robotic technology.
- The company entered a convertible securities agreement with SBC Global Investment Fund for AUD$900,000 initial funding, split into two AUD$450,000 drawdowns.
- Each AUD$450,000 tranche involves issuing 500,000 convertible notes at AUD$1 face value, alongside 4,000,000 placement shares and options exercisable at 130% of VWAP over 36 months.
- A 3% establishment fee applies on the total face value of convertible notes issued, payable in cash or shares at VWAP.
- Additional funding of up to AUD$2.97 million may be drawn within 12 months, subject to mutual consent and standard conditions.
- FBR’s board views the facility as having relatively low dilution risk and a competitive cost of capital compared to other financing alternatives.
Overview of FBR's Robotics Business and Capital Needs
Operating from High Wycombe, Western Australia, FBR Limited develops and deploys robotic solutions across various sectors within Australia. The recent financing arrangement supports the company’s ongoing business operations, focusing on general working capital and operational expenditures. This funding strategy highlights FBR’s proactive capital management amid a competitive technology market where continuous investment in R&D and operational capacity is critical.
The timing of this convertible note facility aligns with FBR’s objective to maintain sufficient liquidity for business continuity and growth. The capital raised will fund operational needs and working capital, with the convertible note structure chosen to balance shareholder interests and limit immediate equity dilution. This arrangement offers flexibility for capital deployment to address evolving operational priorities and market opportunities.
Details of the AUD$900,000 Initial Funding Structure
The convertible securities agreement with SBC Global Investment Fund outlines a two-tranche funding approach for the initial AUD$900,000. Each tranche of AUD$450,000 results in issuing 500,000 convertible notes valued at AUD$1 each. These notes are unsecured liabilities on FBR’s balance sheet, granting SBC conversion rights into ordinary shares or redemption options via cash or share issuance at FBR’s discretion.
This convertible note structure provides FBR with flexibility in liability management, allowing redemption through cash payments or share issuance depending on operational performance and market conditions. The facility delivers immediate working capital support while deferring equity dilution until conversion or redemption. Each tranche also triggers issuance of placement shares and options as part of the agreement.
Placement Shares and Equity Compensation for SBC Global
Under the agreement, FBR will issue 4,000,000 fully paid ordinary shares to SBC Global Investment Fund per tranche. These placement shares represent a significant equity component, issued under FBR’s placement capacity per ASX Listing Rule 7.1 to ensure regulatory compliance.
Issuing placement shares alongside convertible notes creates a layered capital structure, providing SBC with immediate equity exposure plus future conversion rights. The board assesses this structure as having relatively low dilution compared to other financing options, balancing capital cost and shareholder impact.
Options Grant and Exercise Price Terms
SBC Global Investment Fund will receive options exercisable for 36 months from each drawdown date. The exercise price is set at 130% of the VWAP on the trading day before the drawdown. For the initial two tranches, this equates to an exercise price of 17 cents with expiry on 21 July 2029. This pricing mechanism aligns option value with market valuation at funding time.
The 36-month exercise window allows SBC to benefit from share price appreciation above the strike price. The out-of-the-money exercise price aligns SBC’s incentives with FBR’s share price growth. For existing shareholders, dilution from options occurs only upon exercise, providing alignment on long-term value creation.
Establishment Fee and Payment Options
FBR must pay a 3% establishment fee on the total face value of convertible notes at each drawdown, compensating SBC for structuring the facility. This fee can be paid in cash or by issuing shares at VWAP prior to the drawdown, offering FBR cash flow flexibility.
Paying the fee via shares increases dilution beyond placement shares and options but provides cash conservation benefits. The board considers the 3% fee competitive compared to alternative debt or equity financing costs in the current market.
Additional Capital Drawdown Provisions
The agreement allows FBR to draw up to AUD$2.97 million in additional funding within 12 months, subject to mutual agreement and standard conditions. Subsequent tranches follow the same convertible note issuance methodology, with the purchase price multiplied by 10/9 to determine note quantity.
This optionality enables FBR to expand capital access if needed without renegotiating new financing, while protecting both parties through conditional approval. Each additional tranche requires separate compliance documentation and falls within a defined 12-month window.
Regulatory Compliance and Cleansing Statement
The announcement serves as a cleansing statement under section 708A(12C)(e) of the Corporations Act 2001 (Cth), as amended by ASIC Instrument 2026/96. This facilitates secondary market trading of shares issued on note conversion without further disclosure. The statement includes comprehensive disclosures on financial impact, terms, and company prospects, ensuring transparency for investors.
ASIC and ASX disclaim responsibility for the statement’s content, emphasizing FBR’s compliance with regulatory requirements in structuring and disclosing this convertible securities transaction.
Board’s Evaluation of Capital Structure and Shareholder Effects
FBR’s board regards the convertible note facility as having relatively low dilution risk and a favorable cost of capital compared to other financing alternatives. The deferred equity issuance and pricing mechanisms support this view, with the board confident in FBR’s share price performance to justify future conversions.
The board believes this financing approach serves shareholder interests better than immediate equity raises or higher-cost debt, balancing dilution, capital cost, and operational funding needs. Investors are encouraged to assess the potential dilution and cost in light of FBR’s growth prospects and financial performance.
Allocation of Proceeds and Operational Use
Funds raised will be allocated to operational requirements and general working capital rather than specific acquisitions or capital-intensive projects. This supports ongoing cash flow management, payroll, supplier payments, R&D, technology maintenance, and operational infrastructure essential for serving customers.
This general working capital focus reflects organic operational needs rather than targeted strategic investments, allowing management flexibility to address evolving business priorities. Investors should monitor FBR’s operational results and capital deployment effectiveness in subsequent reporting.